Pylarify (piflufolastat F18) NDC: 71258-0022-01
Ended Awarded Last action
- Contract number
- 36C26122N0385
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $4,540,356
Award facts
- Opportunity
-
- 6505--Notice of Intent: PYLARIFY (piflufolastat F 18) Radiopharmaceutical Base plus 4 OY Pre-Solicitation · 36C26122Q0288 · Posted Mar 11, 2022
- Contract value 49% obligated
-
- $4,540,355.95 Current, with exercised options
- $9,293,602.35 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$31,687 | |
| Other Administrative Action | $108,262 | |
| Exercise an Option | $1,083,016 | |
| Supplemental Agreement for work within scope | $108,262 | |
| Supplemental Agreement for work within scope | $400 | |
| Exercise an Option | $1,082,616 | |
| Funding Only Action | -$235,712 | |
| Funding Only Action | -$414,201 | |
| Exercise an Option | $1,082,616 | |
| Exercise an Option | $1,054,071 | |
| Original award | $702,714 |
Show all 11
About this award
Veterans Integrated Service Network 21 issued a delivery order to Progenics Pharmaceuticals Inc. on March 30, 2022, with a ceiling value of $9.29 million for supply of PYLARIFY (piflufolastat F-18), a radiopharmaceutical diagnostic imaging agent, under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB).
The Pharmaceuticals and Drugs schedule is a General Services Administration supply schedule supporting federal healthcare providers' procurement of pharmaceutical products on a firm fixed-price basis. Place of performance is North Billerica, Massachusetts. The ultimate completion date is September 30, 2026. This delivery order carries no set-aside designation.
Quick answers
Who was awarded contract 36C26122N0385?
36C26122N0385 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on March 30, 2022.
How much is contract 36C26122N0385 worth?
The government has obligated $4,540,356 on 36C26122N0385. Its potential value, with all options, is $9,293,602.
Is contract 36C26122N0385 an order under another contract?
Yes. 36C26122N0385 is a delivery order under 36F79719D0170, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26122N0385 competed?
The extent of competition for 36C26122N0385 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award